Table 1

Descriptive statistics for demographic and other clinical risk factors for NTM infection in patients with ESRD

With NTM
diagnosis
Without NTM
diagnosis
OR95% CIP value
Demographics
Age at NTM, years (SD)62.0 (15.6)63.6 (14.9)0.990.99 to 1.00<0.0001
Race, n (%)
 Black1056 (32.7)300 613 (28.2)1.271.18 to 1.37<0.0001
 Other228 (7.1)59 591 (5.6)1.391.21 to 1.59<0.0001
 White1948 (60.3)705 198 (66.2)1.00<0.0001
Sex, n (%)
 Female1280 (39.6)458 374 (43.0)0.870.81 to 0.93<0.0001
 Male1952 (60.4)607 028 (57.0)1.00<0.0001
Ethnicity, n (%)
 Hispanic435 (13.5)156 277 (14.7)0.910.82 to 1.000.0525
 Non-Hispanic2797 (86.5)909 125 (85.3)1.000.0525
First dialysis modality, n (%)
 Hemodialysis3178 (98.3)1 063 593 (99.8)0.100.08 to 0.13<0.0001
 Peritoneal54 (1.7)1809 (0.2)1.00<0.0001
Access type, n (%)
 Catheter2609 (80.7)863 913 (81.1)0.970.87 to 1.070.8506
 Graft108 (3.3)35 535 (3.3)0.980.80 to 1.210.8506
 AV fistula515 (15.9)165 954 (15.6)1.000.8506
Clinical risk factors
Kidney transplant, n (%)656 (20.3)83 468 (7.8)3.002.75 to 3.27<0.0001
HIV, n (%)484 (15.0)11 815 (1.1)15.7114.24 to 17.33<0.0001
Chronic lung disease, n (%)1667 (51.6)334 809 (31.4)2.322.17 to 2.49<0.0001
Cancer, n (%)715 (22.1)147 232 (13.8)1.771.63 to 1.93<0.0001
Diabetes, n (%)2205 (68.2)658 932 (61.9)1.321.23 to 1.43<0.0001
Rheumatologic disease, n (%)780 (24.1)151 616 (14.2)1.921.77 to 2.08<0.0001
Any transplant, n (%)877 (27.1)85 849 (8.1)4.253.93 to 4.60<0.0001
Liver disease, n (%)515 (15.9)88 468 (8.3)2.091.91 to 2.30<0.0001
Cardiovascular disease, n (%)2784 (86.1)738 163 (69.3)2.752.49 to 3.04<0.0001
Mortality
Died, n (%)2314 (71.6)684 225 (64.2)
Alive, n (%)918 (28.4)381 177 (35.8)
Time to death/Follow up, years (SD)2.2 (2.3)3 (2.6)
  • AV, arteriovenous; ESRD, end-stage renal disease; NTM, non-tuberculous mycobacteria.